OR WAIT null SECS
The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.
Lighthouse manufacturing techniques utilize technology and automation to streamline production.
Qualified algorithms enable validation of machine learning models.
May 24, 2022
AstraZeneca's recombinant COVID-19 vaccine, originally invented by the University of Oxford, has been approved as a third dose booster vaccine in the EU.
May 20, 2022
The agency is asking drug manufacturers to ensure a strong supply chain by developing risk management plans.
Catalent has announced a $175 million project to expand its manufacturing facility for large scale oral dose forms at its Winchester, Ky, site.
May 15, 2022
CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.
The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices.
May 13, 2022
Through a collaboration, Avantor and Cytovance Biologics will accelerate plasmid optimization and sourcing services for viral vectors and mRNA-based vaccines and therapeutics.
May 12, 2022
PCI Pharma Services is investing $100 million in manufacturing capabilities and capacity expansion to its Bedford, NH facility.
May 11, 2022
Further development of nucleic acid-based therapeutics has been accelerated by the recent success of mRNA vaccines.
Outsourcing partners are ready to fill the market need for greater cell therapies capacities.
May 09, 2022
MilliporeSigma’s ZooMAb antibodies have been recognized for their low environmental impact by My Green Lab.